0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Radicava- Drug Insight, 2019
Published Date: February 2019
|
Report Code: DELV-DRIN-021
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Radicava Drug Insight 2019

Radicava- Drug Insight, 2019

Code: DELV-DRIN-021
Report
February 2019
35 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

Introduction
DelveInsight's pharmaceuticals report, "Radicava Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Radicava covering the historical global sales and also provides the Radicava sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Radicava and emerging therapies in this space.

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope
• A review of the Radicava, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Reasons to Buy
• Establish a comprehensive understanding of Radicava
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Radicava`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Radicava with DelveInsight`s SWOT analysis

1. DelveInsight Report Introduction
2. Radicava- Overview
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Regulatory Milestones by Region
• Deals and Partnerships
3. Product Details
4. Radicava Sales Assessment
• Historical Sales
• Forecasted Sales
5. Patent Details
6. Global API Manufacturers Assessment
• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region
7. Market Competition
8. Emerging Therapies
8.1 Drug 1: Company 1
• Product Description
• Research and Development
• Product Development Activities
9. SWOT Analysis
Appendix
Methodology
Consulting Services
About DelveInsight
Contact Us
Disclaimer

List for Tables :

Table 1: Radicava, Description
Table 2: Product Details
Table 3: Radicava, Historical Sales till 2018 (in million USD)
Table 4: Radicava, Forecasted Sales from 2019-2021 (in million USD)
Table 5: Patent Details
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region
Table 8: Radicava Major Competitors
Table 9: Emerging Therapies

List for Figures :

Figure 1: Radicava, Historical Global Sales till 2018 (in million USD)
Figure 2: Radicava, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: API Manufacturers by country
Figure 4: API Manufacturers by Region

REPORTS VIEWED RECENTLY

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$1000
This license allows only one user to access the PDF.

Electronic (PDF)
$2000
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$3000
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and China Membrane Bioreactor MBR Systems Market Insights Forecast to 2027
Global and China Membrane Bioreactor (MBR) Systems Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-24N7565
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Oligonucleotide API Market Insights Forecast to 2027
Global and China Oligonucleotide API Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34J7553
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and Japan Prokaryotic Recombinant Protein Market Insights Forecast to 2027
Global and Japan Prokaryotic Recombinant Protein Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-20U7714
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Lentiviral Vector In Gene Therapy Market Insights Forecast to 2027
Global and China Lentiviral Vector In Gene Therapy Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-30V7563
Tue Nov 30 00:00:00 UTC 2021

Add to Cart